Unknown

Dataset Information

0

Induced endothelial cells from peripheral arterial disease patients and neonatal fibroblasts have comparable angiogenic properties.


ABSTRACT: Induced endothelial cells (iECs) generated from neonatal fibroblasts via transdifferentiation have been shown to have pro-angiogenic properties and are a potential therapy for peripheral arterial disease (PAD). It is unknown if iECs can be generated from fibroblasts collected from PAD patients and whether these cells are pro-angiogenic. In this study fibroblasts were collected from four PAD patients undergoing carotid endarterectomies. These cells, and neonatal fibroblasts, were transdifferentiated into iECs using modified mRNA. Endothelial phenotype and pro-angiogenic cytokine secretion were investigated. NOD-SCID mice underwent surgery to induce hindlimb ischaemia in a murine model of PAD. Mice received intramuscular injections with either control vehicle, or 1 × 106 neonatal-derived or 1 × 106 patient-derived iECs. Recovery in perfusion to the affected limb was measured using laser Doppler scanning. Perfusion recovery was enhanced in mice treated with neonatal-derived iECs and in two of the three patient-derived iEC lines investigated in vivo. Patient-derived iECs can be successfully generated from PAD patients and for specific patients display comparable pro-angiogenic properties to neonatal-derived iECs.

SUBMITTER: Hywood JD 

PROVIDER: S-EPMC8354451 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5115826 | biostudies-literature
| EGAS00001004479 | EGA
| S-EPMC8637284 | biostudies-literature
2019-12-20 | GSE142386 | GEO
| S-EPMC3767482 | biostudies-other
| S-EPMC6517203 | biostudies-literature
| S-EPMC4190067 | biostudies-literature